Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Nosopharm S.A.S.. (3/28/17). "Press Release: Nosopharm Raises €2.4 million ($2.6m) to Develop a novel Antibiotic Class". Lyon. 2017-03-28
Sofinnova Partners. (3/28/17). "Press Release: Antoine Papiernik Appointed Chairman of Sofinnova Partners". Paris. 2017-03-28
Erytech Pharma. (3/27/17). "Press Release: Erytech Reports Positive Phase 2b Data for Eryaspase for the Treatment of Metastatic Pancreatic Cancer". Lyon. 2017-03-27
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
Eurofins Scientific. (3/21/17). "Press Release: Eurofins and USP Announce Collaboration to Tackle Food Fraud". 2017-03-21
Symetis AG. (3/20/17). "Press Release: Symetis Launches Its IPO on Euronext Paris [This document may not be released, published or distributed, directly or indirectly, in or into Australia, Canada, Japan or the United States]". 2017-03-20
Advicenne S.A.. (3/20/17). "Press Release: Advicenne Announces the Closing of a €16 Million Financing Round". Nîmes. 2017-03-20
DBV Technologies S.A.. (3/15/17). "Press Release: DBV Technologies Reports Full Year 2016 Financial Results". 2017-03-15
Hybrigenics S.A.. (3/13/17). "Press Release: Strategic Refocusing on Biopharmaceutical R&D". Paris. 2017-03-13
DBV Technologies S.A.. (3/10/17). "Press Release: DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children". 2017-03-10
Servier. (3/9/17). "Press Release: Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia". 2017-03-09
TxCell S.A.. (3/9/17). "Press Release: TxCell 2016 Financial Results". Valbonne. 2017-03-09
Pharnext S.A.. (3/9/17). "Press Release: Pharnext Announces R&D Agreement with Galapagos to Generate a New Pipeline of Synergistic Drug Combinations". Paris. 2017-03-09
Nicox S.A.. (3/9/17). "Press Release: Nicox Resubmits AC-170 (Zerivate) NDA to the U.S. FDA". Sophia Antipolis. 2017-03-09
IntegraGen S.A.. (3/8/17). "Press Release: Laboratoire Cerba Enters into Licensing Agreement with IntegraGen for the Commercialization of miR-31-3p Tumor Expression Test in France, Benelux, Middle East and Africa". Saint-Ouen l’Aumône & Évry. 2017-03-08
Novasep S.A.. (3/7/17). "Press Release: Novasep Appoints Xavier de Saint Guilhem as Chief Financial Officer". Lyon. 2017-03-07
Servier. (3/6/17). "Press Release: Vernalis plc and Servier Enter into a New Drug Discovery Collaboration Strengthening Their Existing Partnership". 2017-03-06
Pierre Fabre S.A.. (3/3/17). "Press Release: Pierre Fabre and Hill Dermaceuticals, Inc. Announce a Strategic Commercial Partnership for Tolak® (fluorouracil) Cream 4% in the USA and Beyond". Lavaur & Sanford, FL. 2017-03-03
bioMérieux S.A.. (3/3/17). "Press Release: 2016 Financial Results". 2017-03-03
Sofinnova Partners. (3/2/17). "Press Release: Sofinnova Partners Raises €106 million in a First Closing of Its Industrial Biotech Fund". Paris. 2017-03-02
Nicox S.A.. (3/1/17). "Press Release: Nicox to Participate at Two Upcoming Investor Conferences". Sophia Antipolis. 2017-03-01
Cerenis Therapeutics S.A.. (3/1/17). "Press Release: Cerenis Therapeutics Announces Top Line Results of CARAT Phase II Study. No Statistical Difference Observed between CER-001 and Placebo". Toulouse & Ann Arbor, MI. 2017-03-01
Genticel S.A.. (2/28/17). "Press Release: Genticel becomes “Genkyotex”. Genticel’s General Meeting Approves the Strategic Combination with GenKyoTex SA [Not for Australia, Canada, Japan, New Zealand, South Africa or the United States]". Toulouse & Geneva 2017-02-28
Genticel S.A.. (2/28/17). "Press Release: Genticel Announces Its 2016 Annual Results". Paris & Toulouse. 2017-02-28
Sanofi S.A.. (2/27/17). "Press Release: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility". Paris & Basel. 2017-02-27
bioMérieux S.A.. (2/24/17). "Press Release: bioMérieux’s VIDAS B•R•A•H•M•S PCT Becomes the First FDA-cleared Procalcitonin Assay as an Aid for Antibiotic Stewardship in Respiratory Infections and Sepsis". 2017-02-24
Valneva S.E.. (2/23/17). "Press Release: Valneva Reports Strong Q4 and FY 2016 Business Performance, Expects Further Growth in Sales and EBITDA, R&D Progress in 2017". Lyon. 2017-02-23
Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris. 2017-02-23
TxCell S.A.. (2/22/17). "Press Release: TxCell Successfully Completes a €11 Million Capital Increase [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan]". Valbonne. 2017-02-22
Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris. 2017-02-21
Sartorius Stedim Biotech S.A.. (2/21/17). "Press Release: Resolutions by the Board of Directors". Aubagne. 2017-02-21
Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. 2017-02-21
Biophytis S.A.. (2/21/17). "Press Release: Biophytis Relocates to Pierre and Marie Curie University (UPMC) Campus and Solidifies Creation of Leading Translational Platform for Age-related Disease". Paris. 2017-02-21
Cerenis Therapeutics S.A.. (2/17/16). "Press Release: 2016 Annual Results. Solid Cash Position of €24.7 million and Finalization of CARAT Phase 2 Clinical Study". Toulouse & Ann Arbor, MI. 2017-02-17
Euronext N.V.. (2/15/17). "Press Release: Inventiva Lists on Euronext Paris. €48 Million Raised, Market Capitalisation €133 Million". Paris. 2017-02-15
Servier. (2/14/17). "Press Release: Servier and GAIA Extend Their Partnership to Provide Patients around the World with Deprexis, an Internet-based Cognitive Behavioral Therapy for Depression". Suresnes & Hamburg. 2017-02-14
Immunicum AB. (2/14/17). "Press Release: Immunicum AB Announces Approval in France for Its Clinical Trial Application for Intuvax in Metastatic Renal Cell Carcinoma". Gothenburg. 2017-02-14
Ipsen S.A.. (2/13/17). "Press Release: Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi". Paris. 2017-02-13
Premaitha Health plc. (2/13/17). "Press Release: New Partnership with Major European Diagnostics Group". Manchester. 2017-02-13
Nicox S.A.. (2/9/17). "Press Release: Nicox to Present at the 6th Annual Leerink Partners Global Healthcare Conference". Sophia Antipolis. 2017-02-09
Neovacs S.A.. (2/9/17). "Press Release: Neovacs Issued New Broad Patent in China for IFNalpha Kinoid". Paris. 2017-02-09
Euronext N.V.. (2/8/17). "Press Release: Lysogene Lists on Euronext. €22.6 Million Raised, Market Capitalisation of approximately €82 Million". Paris. 2017-02-08
Global Bioenergies S.A.. (2/7/17). "Press Release: First Production in History of Fully Renewable ETBE". Évry. 2017-02-07
Pharnext S.A.. (2/7/17). "Press Release: Pharnext to Present at 2017 BIO CEO & Investor Conference". Paris. 2017-02-07
OSE Immunotherapeutics S.A.. (2/7/17). "Press Release: OSE Immunotherapeutics to Present Corporate Overview at Upcoming BIO CEO & Investor Conference New York February 13-14, 2017". Nantes. 2017-02-07
Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. 2017-02-07
IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. 2017-02-03
Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. 2017-02-03
Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. 2017-02-02
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. 2017-01-31
ElsaLys Biotech S.A.S.. (1/30/17). "Press Release: ElsaLys Biotech Expands Its Team to Strengthen Its Strategy and the Development of Its Programs". Lyon. 2017-01-30
Sanofi S.A.. (1/30/17). "Press Release: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs". Paris. 2017-01-30
Recordati Industria Chimica e Farmaceutica S.p.A.. (1/27/17). "Press Release: Recordati Announces Marketing Approval for Cystadrops". Milan. 2017-01-27
TxCell S.A.. (1/25/17). "Press Release: Txcell Launches a Capital Increase of around 11 Million Euros with Shareholders’ Preferential Subscription Rights [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan] 2017-01-25
Sensorion S.A.. (1/25/17). "Press Release: Sensorion to Receive €950,000 from Bpifrance and the Occitania Region". Montpellier. 2017-01-25
Lysogene S.A.. (1/25/17). "Press Release: Lysogene Launches Its IPO on Euronext’s Regulated Market in Paris". 2017-01-25
Neovacs S.A.. (1/25/17). "Press Release: Neovacs Reports First Positive Immunogenicity Results for IFN alpha Kinoid in Model of Type 1 Diabetes". Paris & Boston, MA. 2017-01-25
Domain Therapeutics S.A.. (1/23/17). "Press Release: Domain Therapeutics and Merck Enter into a License and Collaboration Agreement for Development of Adenosine Receptor Antagonists in Immuno-oncology". Strasbourg. 2017-01-23
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. 2017-01-19
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. 2017-01-19
Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. 2017-01-18
Sanofi S.A.. (1/18/17). "Press Release: Suliqua Approved in the European Union for the Treatment of Adults with Type 2 Diabetes". Paris. 2017-01-18
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. 2017-01-09
Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. 2017-01-09
IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. 2017-01-09
Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris. 2017-01-09
McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. 2017-01-06
Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. 2017-01-05
Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. 2017-01-05
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. 2017-01-05
Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris. 2017-01-04
Pharnext S.A.. (1/3/17). "Press Release: Pharnext Announces the Amendment to the Liquidity Contract with French Broker Gilbert Dupont and the Annual Update on Its Liquidity Agreement". Paris. 2017-01-03
Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY. 2017-01-03
Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY. 2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. 2017-01-02
OSE Immunotherapeutics S.A.. (12/28/16). "Press Release: OSE Immunotherapeutics Signs a License Option Agreement with Servier to Develop and Commercialize the Product Effi-7". Nantes & Paris. 2016-12-28
Genticel S.A.. (12/22/16). "Press Release: Genticel and Genkyotex Announce Intention to Enter into Strategic Combination [Not for Australia, Canada, Japan, New Zealand, South Africa, or the United States]". Toulouse & Geneva. 2016-12-22
Pharnext S.A.. (12/20/16). "Press Release: Pharnext Completes Patient Enrollment in International Pivotal Phase 3 Trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1A". Paris. 2016-12-20
Innate Pharma S.A.. (12/19/16). "Press Release: Innate Pharma Announces Key Leadership and Corporate Governance Changes to Support Next Stage of Development". Marseille. 2016-12-19
Novacyt S.A.. (12/15/16). "Press Release: Novacyt Successfully Completes €2.7m Fundraising". Paris & Cambridge. 2016-12-15
Valneva S.E.. (12/15/16). "Press Release: Valneva Confirms Closing of Private Placement in Connection with €15.2m Investment by MVM Life Science Partners". Lyon. 2016-12-15
Cellectis S.A.. (12/15/16). "Press Release: Cellectis Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of UCART123 Phase 1 Study Protocols in AML and BPDCN". New York, NY. 2016-12-15
Abivax S.A.. (12/15/16). "Press Release: Abivax Appoints Didier Blondel as Chief Financial Officer". Paris. 2016-12-15
TxCell S.A.. (12/14/16). "Press Release: TxCell Provides Update on Its Strengthened IP Portfolio". Valbonne. 2016-12-14
Genticel S.A.. (12/13/16). "Press Release: Genticel Reports Final Results of GTL001 Phase 2 Trial in HPV16/18-infected Women". Paris & Toulouse. 2016-12-13
Sanofi S.A.. (12/8/16). "Press Release: Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent (dupilumab) Accepted for Review by the EMA". Paris & Tarrytown, NY. 2016-12-08
TxCell S.A.. (12/8/16). "Press Release: TxCell Signs In-licensing Global Agreement with Inserm Transfert for Novel Population of Regulatory T Cells". Valbonne & Nantes. 2016-12-08
Transgene S.A.. (12/7/16). "Press Release: UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)". Strasbourg. 2016-12-07
Lysogene S.A.. (12/7/16). "Press Release: Lysogene Appoints David Schilansky to Board of Directors". Paris. 2016-12-07
Biomunex Pharmaceuticals SASU. (12/5/16). "Press Release: Biomunex Appoints Dr. Sebastian Amigorena and Dr. Dragan Grabulovski as Key Scientific and Strategic Advisors". Paris. 2016-12-05
Theradiag S.A.. (12/1/16). "Press Release: US Launch of the Fifth Test in the LISA Tracker Range". Croissy-Beaubourg & Montpellier. 2016-12-01
Oncodesign S.A.. (12/1/16). "Press Release: Oncodesign Completes the Acquisition of François Hyafil Research Centre and Appoints Two New Strategic Activity Directors". Dijon. 2016-12-01
Valneva S.E.. (12/1/16). "Press Release: Leading Healthcare Investor MVM Life Science Partners Acquires 7.5% Shareholding in Valneva". Lyon. 2016-12-01
Genticel S.A.. (11/30/16). "Press Release: Genticel Successfully Completes Determining Milestone in Partnership with Serum Institute Regarding Use of GTL003 in Multivalent Vaccines". Paris & Toulouse. 2016-11-30
TxCell S.A.. (11/29/16). "Press Release: TxCell Completes Aligning Operations with Strategic Refocus. Resources Now Focused on Promising CAR-Treg Programs". Valbonne. 2016-11-29
Carbios S.A.. (11/28/16). "Press Release: Carbios – New Success with the Development of a Depolymerization Process at 100% of Plastic Bottles". Clermont-Ferrand. 2016-11-28
Neovacs S.A.. (11/23/16). "Press Release: Neovacs Signs Production Partnership with 3P Biopharmaceuticals, a Leading GMP Producer of Biological Drugs". Paris & Boston, MA. 2016-11-23
Cellectis S.A.. (11/22/16). "Press Release: Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016". New York, NY. 2016-11-22
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top